Back to Search
Start Over
Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.
- Source :
- Quality of Life Research; Sep2017, Vol. 26 Issue 9, p2333-2349, 17p, 2 Diagrams, 7 Charts, 1 Graph
- Publication Year :
- 2017
-
Abstract
- <bold>Purpose: </bold>To report the results of a randomized controlled trial using an electronic monitoring device (EM) plus a motivational interviewing (MI) intervention to enhance adherence to disease-modifying therapies (DMT) in pediatric MS.<bold>Methods: </bold>Fifty-two youth with MS (16.03 ± 2.2 years) were randomized to receive either MI (n = 25) (target intervention) or a MS medication video (n = 27) (attention control). Primary endpoint was change in adherence. Secondary outcomes included changes in quality of life, well-being and self-efficacy. Random effects modeling and Cohen's effect size computation evaluated intervention impact.<bold>Results: </bold>Longitudinal random effect models revealed that the MI group decreased their EM adherence (GroupxTime interaction = -0.19), while increasing frequency of parental DMT reminder (26.01)/administration (11.69). We found decreased EM use in the MI group at 6 months (Cohen's d = -0.61), but increased pharmacy refill adherence (d = 0.23). Parental reminders about medication increased in MI subjects vs controls (d = 0.59 at 3 months; d = 0.70 at 6 months). We found increases in self-reported adherence (d = 0.21) at 3 but not 6 months, fewer barriers to adherence at three (d = -0.58) and six months (d = -0.31), better physical (d = 0.23 at 3 months; d = 0.45 at 6 months), emotional (d = 0.25 at 3 months) and self-efficacy function (d = 0.55 at 3 months; 0.48 at 6 months), but worse well-being, including self-acceptance (d = -0.53 at 6 months) and environmental mastery (d = -0.42 at 3 and 6 months) in intervention as compared to control patients.<bold>Conclusions: </bold>Participants receiving MI + EM experienced worsening on objective measures of adherence and increased parental involvement, but improved on some self- and parent-reported measures. MI participants reported improvements in quality of life and self-efficacy, but worsened well-being. [ABSTRACT FROM AUTHOR]
- Subjects :
- MULTIPLE sclerosis treatment
QUALITY of life
PATIENT monitoring
CLINICAL trials
PATIENT compliance
DISEASES in youths
MENTAL health
COMPARATIVE studies
DRUGS
HEALTH behavior
RESEARCH methodology
MEDICAL cooperation
MULTIPLE sclerosis
RESEARCH
RESEARCH funding
EVALUATION research
RANDOMIZED controlled trials
Subjects
Details
- Language :
- English
- ISSN :
- 09629343
- Volume :
- 26
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- Quality of Life Research
- Publication Type :
- Academic Journal
- Accession number :
- 124517145
- Full Text :
- https://doi.org/10.1007/s11136-017-1571-z